1193 related articles for article (PubMed ID: 21071074)
1. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial.
Lester RT; Ritvo P; Mills EJ; Kariri A; Karanja S; Chung MH; Jack W; Habyarimana J; Sadatsafavi M; Najafzadeh M; Marra CA; Estambale B; Ngugi E; Ball TB; Thabane L; Gelmon LJ; Kimani J; Ackers M; Plummer FA
Lancet; 2010 Nov; 376(9755):1838-45. PubMed ID: 21071074
[TBL] [Abstract][Full Text] [Related]
2. Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial.
Gross R; Ritz J; Hughes MD; Salata R; Mugyenyi P; Hogg E; Wieclaw L; Godfrey C; Wallis CL; Mellors JW; Mudhune VO; Badal-Faesen S; Grinsztejn B; Collier AC
Lancet Digit Health; 2019 May; 1(1):e26-e34. PubMed ID: 31528850
[TBL] [Abstract][Full Text] [Related]
3. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.
Horvath T; Azman H; Kennedy GE; Rutherford GW
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD009756. PubMed ID: 22419345
[TBL] [Abstract][Full Text] [Related]
4. The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol.
Lester RT; Mills EJ; Kariri A; Ritvo P; Chung M; Jack W; Habyarimana J; Karanja S; Barasa S; Nguti R; Estambale B; Ngugi E; Ball TB; Thabane L; Kimani J; Gelmon L; Ackers M; Plummer FA
Trials; 2009 Sep; 10():87. PubMed ID: 19772596
[TBL] [Abstract][Full Text] [Related]
5. The effect of an interactive weekly mobile phone messaging on retention in prevention of mother to child transmission (PMTCT) of HIV program: study protocol for a randomized controlled trial (WELTEL PMTCT).
Awiti PO; Grotta A; van der Kop M; Dusabe J; Thorson A; Mwangi J; Belloco R; Lester R; Ternent L; Were E; Ekström AM
BMC Med Inform Decis Mak; 2016 Jul; 16():86. PubMed ID: 27401475
[TBL] [Abstract][Full Text] [Related]
6. Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.
King E; Kinvig K; Steif J; Qiu AQ; Maan EJ; Albert AY; Pick N; Alimenti A; Kestler MH; Money DM; Lester RT; Murray MCM
J Med Internet Res; 2017 Jun; 19(6):e190. PubMed ID: 28572079
[TBL] [Abstract][Full Text] [Related]
7. In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial.
van der Kop ML; Karanja S; Thabane L; Marra C; Chung MH; Gelmon L; Kimani J; Lester RT
PLoS One; 2012; 7(9):e46033. PubMed ID: 23049928
[TBL] [Abstract][Full Text] [Related]
8. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages.
da Costa TM; Barbosa BJ; Gomes e Costa DA; Sigulem D; de Fátima Marin H; Filho AC; Pisa IT
Int J Med Inform; 2012 Apr; 81(4):257-69. PubMed ID: 22296762
[TBL] [Abstract][Full Text] [Related]
9. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.
Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V;
BMJ; 2014 Oct; 349():g5978. PubMed ID: 25742320
[TBL] [Abstract][Full Text] [Related]
10. The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: study protocol for a randomised controlled trial (WelTel Retain).
van der Kop ML; Ojakaa DI; Patel A; Thabane L; Kinagwi K; Ekström AM; Smillie K; Karanja S; Awiti P; Mills E; Marra C; Kyomuhangi LB; Lester RT
BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794578
[TBL] [Abstract][Full Text] [Related]
11. Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): an open-label, randomised parallel-group study.
van der Kop ML; Muhula S; Nagide PI; Thabane L; Gelmon L; Awiti PO; Abunah B; Kyomuhangi LB; Budd MA; Marra C; Patel A; Karanja S; Ojakaa DI; Mills EJ; Ekström AM; Lester RT
Lancet Public Health; 2018 Mar; 3(3):e143-e152. PubMed ID: 29361433
[TBL] [Abstract][Full Text] [Related]
12. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
13. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.
Gross R; Zheng L; La Rosa A; Sun X; Rosenkranz SL; Cardoso SW; Ssali F; Camp R; Godfrey C; Cohn SE; Robbins GK; Chisada A; Wallis CL; Reynolds NR; Lu D; Safren SA; Hosey L; Severe P; Collier AC;
Lancet HIV; 2015 Jan; 2(1):e12-9. PubMed ID: 26424232
[TBL] [Abstract][Full Text] [Related]
14. Mobile phones to improve HIV treatment adherence.
Chi BH; Stringer JS
Lancet; 2010 Nov; 376(9755):1807-8. PubMed ID: 21071073
[No Abstract] [Full Text] [Related]
15. Effect of a clinical decision support system on early action on immunological treatment failure in patients with HIV in Kenya: a cluster randomised controlled trial.
Oluoch T; Katana A; Kwaro D; Santas X; Langat P; Mwalili S; Muthusi K; Okeyo N; Ojwang JK; Cornet R; Abu-Hanna A; de Keizer N
Lancet HIV; 2016 Feb; 3(2):e76-84. PubMed ID: 26847229
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of short message services and voice call interventions for antiretroviral therapy adherence and other outcomes: A systematic review and meta-analysis.
Amankwaa I; Boateng D; Quansah DY; Akuoko CP; Evans C
PLoS One; 2018; 13(9):e0204091. PubMed ID: 30240417
[TBL] [Abstract][Full Text] [Related]
18. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders.
Pop-Eleches C; Thirumurthy H; Habyarimana JP; Zivin JG; Goldstein MP; de Walque D; MacKeen L; Haberer J; Kimaiyo S; Sidle J; Ngare D; Bangsberg DR
AIDS; 2011 Mar; 25(6):825-34. PubMed ID: 21252632
[TBL] [Abstract][Full Text] [Related]
19. The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy.
Mbuagbaw L; Thabane L; Ongolo-Zogo P; Lester RT; Mills E; Volmink J; Yondo D; Essi MJ; Bonono-Momnougui RC; Mba R; Ndongo JS; Nkoa FC; Ondoa HA
Trials; 2011 Jan; 12():5. PubMed ID: 21211064
[TBL] [Abstract][Full Text] [Related]
20. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
